Apellis Pharmaceuticals Inc (APLS) USD0.0001
0.66%- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$25.22
Buy:$25.24
Change:
$1.90
(8.21%)
$1.90
(8.21%)Market closed |
Prices delayed by at least 15 minutes
Sell:$25.22
Buy:$25.24
Change:$1.90
(8.21%)
$1.90
(8.21%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 30 September 2025 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 31,092 | $22.58 | $702,057.36 | 33,979 |
| 19 September 2025 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 31,092 | $22.95 | $713,561.40 | 68,908 |
| 16 September 2025 | David O WatsonGeneral Counsel | Sell Regular sell transaction (market) | 5,000 | $24.34 | $121,700.00 | 118,730 |
| 15 September 2025 | James George (Jim) ChopasChief Accounting Officer | Sell Tax related | 189 | $24.19 | $4,572.29 | 53,468 |
| 10 September 2025 | David O WatsonGeneral Counsel | Sell Regular sell transaction (market) | 20,000 | $26.17 | $523,400.00 | 50,136 |
| 8 September 2025 | Timothy Eugene (Tim) SullivanCFO | Sell Regular sell transaction (market) | 32,729 | $27.86 | $911,829.94 | 110,936 |
| 8 September 2025 | Timothy Eugene (Tim) SullivanCFO | Sell Option/Award related | 10,000 | $27.83 | $278,300.00 | 60,396 |
| 2 September 2025 | James George (Jim) ChopasChief Accounting Officer | Sell Tax related | 548 | $28.08 | $15,386.20 | 53,657 |
| 28 August 2025 | Cedric G FrancoisChairman/CEO | Sell Regular sell transaction (market) | 49,963 | $28.39 | $1,418,449.57 | 307,946 |
| 27 August 2025 | Cedric G FrancoisChairman/CEO | Sell Regular sell transaction (market) | 175,037 | $28.19 | $4,934,293.03 | 357,909 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 27 August 2025 | Cedric G FrancoisChairman/CEO | Sell Regular sell transaction (market) | 175,037 | $28.19 | $4,934,293.03 | 357,909 |
| 14 July 2025 | Cedric G FrancoisChairman/CEO | Sell Regular sell transaction (market) | 137,465 | $20.19 | $2,774,923.48 | 343,433 |
| 28 August 2025 | Cedric G FrancoisChairman/CEO | Sell Regular sell transaction (market) | 49,963 | $28.39 | $1,418,449.57 | 307,946 |
| 8 September 2025 | Timothy Eugene (Tim) SullivanCFO | Sell Regular sell transaction (market) | 32,729 | $27.86 | $911,829.94 | 110,936 |
| 19 September 2025 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 31,092 | $22.95 | $713,561.40 | 68,908 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.